FI113940B - Menetelmä välineen valmistamiseksi hyödyllisen aineen toimittamiseksi vesipitoiseen ympäristöön - Google Patents

Menetelmä välineen valmistamiseksi hyödyllisen aineen toimittamiseksi vesipitoiseen ympäristöön Download PDF

Info

Publication number
FI113940B
FI113940B FI952461A FI952461A FI113940B FI 113940 B FI113940 B FI 113940B FI 952461 A FI952461 A FI 952461A FI 952461 A FI952461 A FI 952461A FI 113940 B FI113940 B FI 113940B
Authority
FI
Finland
Prior art keywords
coating
solubility
agent
beneficial agent
release
Prior art date
Application number
FI952461A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI952461A0 (fi
FI952461A (fi
Inventor
Avinash Govind Thombre
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI952461A0 publication Critical patent/FI952461A0/fi
Publication of FI952461A publication Critical patent/FI952461A/fi
Application granted granted Critical
Publication of FI113940B publication Critical patent/FI113940B/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Inductance-Capacitance Distribution Constants And Capacitance-Resistance Oscillators (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Pigments, Carbon Blacks, Or Wood Stains (AREA)
FI952461A 1992-11-20 1995-05-19 Menetelmä välineen valmistamiseksi hyödyllisen aineen toimittamiseksi vesipitoiseen ympäristöön FI113940B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US97972792A 1992-11-20 1992-11-20
US97972792 1992-11-20
US9309582 1993-10-13
PCT/US1993/009582 WO1994012152A1 (en) 1992-11-20 1993-10-13 Delivery device having encapsulated excipients

Publications (3)

Publication Number Publication Date
FI952461A0 FI952461A0 (fi) 1995-05-19
FI952461A FI952461A (fi) 1995-05-19
FI113940B true FI113940B (fi) 2004-07-15

Family

ID=25527106

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952461A FI113940B (fi) 1992-11-20 1995-05-19 Menetelmä välineen valmistamiseksi hyödyllisen aineen toimittamiseksi vesipitoiseen ympäristöön

Country Status (21)

Country Link
US (1) US5697922A (el)
EP (1) EP0668755B1 (el)
JP (1) JP2842944B2 (el)
KR (1) KR950703931A (el)
CN (1) CN1090488A (el)
AT (1) ATE168886T1 (el)
AU (1) AU5353694A (el)
CA (1) CA2148837C (el)
DE (1) DE69320056T2 (el)
DK (1) DK0668755T3 (el)
ES (1) ES2118263T3 (el)
FI (1) FI113940B (el)
GR (1) GR3027676T3 (el)
IL (1) IL107567A0 (el)
MX (1) MX9307256A (el)
MY (1) MY134742A (el)
NO (1) NO311403B1 (el)
NZ (1) NZ257239A (el)
TW (1) TW235239B (el)
WO (1) WO1994012152A1 (el)
ZA (1) ZA938656B (el)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514533B1 (en) * 1992-06-11 2003-02-04 Alkermas Controlled Therapeutics, Inc. Device for the sustained release of aggregation-stabilized, biologically active agent
IN186245B (el) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6391336B1 (en) 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
WO2003024427A1 (en) 1999-12-20 2003-03-27 Temple University Of The Commonwealth System Of Higher Education Tableted oral extended release dosage form
US6936275B2 (en) 1999-12-20 2005-08-30 Scolr, Inc. Amino acid modulated extended release dosage form
US6599532B2 (en) * 2000-01-13 2003-07-29 Osmotica Corp. Osmotic device containing alprazolam and an antipsychotic agent
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
DE60223695T2 (de) * 2001-09-14 2008-10-30 Scolr, Inc., Redmond Aminosäure-modulierte dosierform mit verlängerter freisetzung
JP2004075582A (ja) * 2002-08-13 2004-03-11 Takeda Chem Ind Ltd 固形医薬組成物に処方される有効成分以外の成分の安定化方法
US8980870B2 (en) * 2002-09-24 2015-03-17 Boehringer Ingelheim International Gmbh Solid telmisartan pharmaceutical formulations
US6893660B2 (en) * 2002-11-21 2005-05-17 Andrx Pharmaceuticals, Inc. Stable pharmaceutical compositions without a stabilizer
US20050053669A1 (en) * 2003-09-05 2005-03-10 Boehringer Ingelheim International Gmbh Administration form for the oral application of poorly soluble acidic and amphorteric drugs
US7611728B2 (en) * 2003-09-05 2009-11-03 Supernus Pharmaceuticals, Inc. Osmotic delivery of therapeutic compounds by solubility enhancement
WO2005124931A1 (en) * 2004-06-08 2005-12-29 Paricon Technologies Corporation Apparatus for applying a mechanically-releasable balanced compressive load to an assembly such as a compliant anisotropic conductive elastomer electrical connector
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
EP1837364A1 (fr) * 2006-03-20 2007-09-26 A. Weber (Société Anonyme) Procédé de neutralisation de l'acidité résiduelle contenue dans les composés phénoliques
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
CA2612989A1 (en) * 2006-05-08 2007-11-08 Mcneil-Ppc, Inc. Osmotic dosage form
JP2012505211A (ja) * 2008-10-10 2012-03-01 アルヴィン ファーマシューティカルズ インコーポレーティッド チモーゲンの迅速な活性化を促進する剤形
US20100143486A1 (en) * 2008-12-10 2010-06-10 Nipun Davar Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
US20100266682A1 (en) * 2008-12-10 2010-10-21 Nipun Davar Polyethylene glycol-coated sodium carbonate as a pharmaceutical excipient and compositions produced from the same
EP2228066A1 (en) * 2009-03-03 2010-09-15 LEK Pharmaceuticals d.d. Pharmaceutical compositions of sulphonylurea-based active pharmaceutical ingredient with excellent dissolution properties
CN102113961B (zh) * 2011-01-25 2013-11-13 浙江工业大学 一种不对称膜渗透泵胶囊壳的制备方法
US9670437B2 (en) * 2013-10-07 2017-06-06 Monosol, Llc Water-soluble delayed release capsules, related methods, and related articles

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111201A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4608048A (en) * 1984-12-06 1986-08-26 Alza Corporation Dispensing device with drug delivery patterns
US4755180A (en) * 1986-06-16 1988-07-05 Alza Corporation Dosage form comprising solubility regulating member
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer A device for the controlled release of pneumatic substances, including the active substance, surrounded by an asymmetric membrane
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
US5260068A (en) * 1992-05-04 1993-11-09 Anda Sr Pharmaceuticals Inc. Multiparticulate pulsatile drug delivery system

Also Published As

Publication number Publication date
DK0668755T3 (da) 1998-11-02
NZ257239A (en) 1996-08-27
NO311403B1 (no) 2001-11-26
CA2148837C (en) 1998-07-14
ATE168886T1 (de) 1998-08-15
IL107567A0 (en) 1994-02-27
AU5353694A (en) 1994-06-22
EP0668755A1 (en) 1995-08-30
MY134742A (en) 2007-12-31
DE69320056T2 (de) 1998-12-10
FI952461A0 (fi) 1995-05-19
GR3027676T3 (en) 1998-11-30
NO951996D0 (no) 1995-05-19
JP2842944B2 (ja) 1999-01-06
KR950703931A (ko) 1995-11-17
TW235239B (el) 1994-12-01
US5697922A (en) 1997-12-16
ZA938656B (en) 1995-05-18
FI952461A (fi) 1995-05-19
NO951996L (no) 1995-05-19
ES2118263T3 (es) 1998-09-16
MX9307256A (es) 1994-05-31
CN1090488A (zh) 1994-08-10
CA2148837A1 (en) 1994-06-09
DE69320056D1 (de) 1998-09-03
EP0668755B1 (en) 1998-07-29
JPH07508762A (ja) 1995-09-28
WO1994012152A1 (en) 1994-06-09

Similar Documents

Publication Publication Date Title
FI113940B (fi) Menetelmä välineen valmistamiseksi hyödyllisen aineen toimittamiseksi vesipitoiseen ympäristöön
EP0542364B1 (en) Controlled release device
FI94025C (fi) Vaikuttavaa ainetta säädellysti vapauttava väline
JP2853903B2 (ja) 蒸気透過性コーチングを有する浸透デバイス
KR0176724B1 (ko) 액상 약물 전달용 삼투 투약 시스템
AU685297B2 (en) Tacrine pharmaceutical compositions
CA2473200C (en) Extended release compositions comprising as active compound venlafaxine hydrochloride
FI111516B (fi) Hyödyllisen aineen kontrolloiduksi annostelemiseksi tarkoitettu väline
FI104950B (fi) Menetelmä glipitsidiä sisältävän annosmuodon valmistamiseksi
CA1338552C (en) Use of asymmetric membranes in delivery devices
JPS61249916A (ja) 不活性なコア部を有する浸透圧利用薬剤投与具
CA2851765C (en) A gastroretentive dosage system and process of preparation thereof
JP2005521706A (ja) 体積効果的放出制御製剤
KR20140069381A (ko) 서방출 투여형
JPH0798748B2 (ja) ベラパミルの投与用製剤
JP2003516345A (ja) 抗ウイルス剤
EA026830B1 (ru) Осмотически активная система вагинальной доставки
US20040058000A1 (en) Controlled release capsule for delivery of liquid formulation
Barzegar-Jalali et al. Design and Evaluation of Delayed-Release Osmotic Capsule of Acetaminophen: Delayed-release osmotic capsule of acetaminophen
DK175608B1 (da) Hidtil ukendt doseringsform
US20040062799A1 (en) Therapeutic composition and delivery system for administering drug